These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 26355599

  • 21. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 22. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
    Zhang X, Kang Y, Huo T, Tao R, Wang X, Li Z, Guo Q, Zhao L.
    Free Radic Biol Med; 2017 Nov 06; 112():49-59. PubMed ID: 28697922
    [Abstract] [Full Text] [Related]

  • 23. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.
    Int J Oncol; 2013 Mar 06; 42(3):971-8. PubMed ID: 23338043
    [Abstract] [Full Text] [Related]

  • 24. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P, Chen L, Li LH, Wei ZF, Tong B, Jia YG, Kong LY, Xia YF, Dai Y.
    BMC Cancer; 2014 Dec 19; 14():987. PubMed ID: 25527123
    [Abstract] [Full Text] [Related]

  • 25. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW, Jang EJ, Kim CH, Lee JH.
    Chem Biol Interact; 2017 Jan 05; 261():108-117. PubMed ID: 27871897
    [Abstract] [Full Text] [Related]

  • 26. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
    Höpfner M, Huether A, Sutter AP, Baradari V, Schuppan D, Scherübl H.
    Biochem Pharmacol; 2006 May 14; 71(10):1435-48. PubMed ID: 16530734
    [Abstract] [Full Text] [Related]

  • 27. Cantharidin inhibits cell proliferation and induces apoptosis through G2/M phase cell cycle arrest in hepatocellular carcinoma stem cells.
    Le AP, Zhang LL, Liu W, Shi YF.
    Oncol Rep; 2016 May 14; 35(5):2970-6. PubMed ID: 26986084
    [Abstract] [Full Text] [Related]

  • 28. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
    Chen YL, Yan MY, Chien SY, Kuo SJ, Chen DR, Cheng CY, Su CC.
    Mol Med Rep; 2013 May 14; 7(5):1487-93. PubMed ID: 23525225
    [Abstract] [Full Text] [Related]

  • 29. Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.
    Perng DS, Tsai YH, Cherng J, Wang JS, Chou KS, Shih CW, Cherng JM.
    Drug Des Devel Ther; 2016 May 14; 10():141-53. PubMed ID: 26792981
    [Abstract] [Full Text] [Related]

  • 30. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q, Ching AK, Leung WK, Szeto CY, Ho SM, Chan PK, Yuan YF, Lai PB, Yeo W, Wong N.
    Int J Oncol; 2011 Mar 14; 38(3):721-31. PubMed ID: 21240457
    [Abstract] [Full Text] [Related]

  • 31. 5,6-Dihydroxy-3,7,4'-trimethoxyflavonol induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
    Zhao XX, Chang JJ, Wang QL, Lu R, Li LJ, Sun X, Xie WD, Li X.
    J Asian Nat Prod Res; 2016 Nov 14; 18(11):1079-90. PubMed ID: 27314303
    [Abstract] [Full Text] [Related]

  • 32. Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway.
    Han M, Gao H, Xie J, Yuan YP, Yuan Q, Gao MQ, Liu KL, Chen XH, Han YT, Han ZW.
    Acta Pharmacol Sin; 2019 May 14; 40(5):666-676. PubMed ID: 30218072
    [Abstract] [Full Text] [Related]

  • 33. (-)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma.
    Lu IT, Lin SC, Chu YC, Wen Y, Lin YC, Cheng WC, Sheu JH, Lin CC.
    Mar Drugs; 2022 Jan 29; 20(2):. PubMed ID: 35200638
    [Abstract] [Full Text] [Related]

  • 34. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ, Chang LH, Chang CM, Hsu SL, Teng CL, Wu CC.
    J Agric Food Chem; 2012 Sep 26; 60(38):9620-30. PubMed ID: 22946656
    [Abstract] [Full Text] [Related]

  • 35. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.
    Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q.
    Cancer Lett; 2009 Nov 18; 285(1):13-22. PubMed ID: 19647933
    [Abstract] [Full Text] [Related]

  • 36. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.
    Kumar A, Singh B, Mahajan G, Sharma PR, Bharate SB, Mintoo MJ, Mondhe DM.
    Tumour Biol; 2016 Oct 18; 37(10):13121-13136. PubMed ID: 27449046
    [Abstract] [Full Text] [Related]

  • 37. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N, Streit S, Wybranski C, Jürgens J, Brauner J, Schulz N, Powerski M, Ricke J, Kalinski T, Dudeck O, Seidensticker M.
    Anticancer Res; 2017 Jan 18; 37(1):87-93. PubMed ID: 28011478
    [Abstract] [Full Text] [Related]

  • 38. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y, Poon RT, Li Q, Kok TW, Lau C, Fan ST.
    Cancer Res; 2005 May 01; 65(9):3691-9. PubMed ID: 15867364
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.